Financial Information
Statements of Cash Flows
(Unit:millions of yen)
2022/10 | 2023/10 | |
Cash flows from operating activities | ||
Profit before income taxes | 1,905 | 2,210 |
Depreciation | 7,631 | 8,837 |
Impairment losses | 506 | 590 |
Interest income | -73 | -283 |
Interest expenses | 223 | 272 |
Subsidy income | -3,129 | -29 |
Decrease (increase) in inventories | -566 | -91 |
Decrease (increase) in trade receivables | -1,030 | -499 |
Increase (decrease) in trade payables | 396 | 408 |
Increase (decrease) in accrued consumption taxes | -796 | 662 |
Other, net | 2,349 | 2,112 |
Subtotal | 7,414 | 14,190 |
Interest received | 33 | 243 |
Interest paid | -223 | -272 |
Subsidies received | 5,042 | 33 |
Income taxes paid | -2,323 | -465 |
Net cash provided by (used in) operating activities | 9,944 | 13,727 |
Cash flows from investing activities | ||
Purchase of securities | - | -1,287 |
Proceeds from redemption of securities | - | 103 |
Purchase of property, plant and equipment | -10,129 | -11,771 |
Proceeds from sale of property, plant and equipment | - | 34 |
Purchase of intangible assets | -401 | -543 |
Purchase of shares of subsidiaries and associates | -293 | - |
Loan advances | -484 | -603 |
Payments of guarantee deposits | -563 | -345 |
Proceeds from refund of guarantee deposits | 82 | 98 |
Other, net | -315 | -229 |
Net cash provided by (used in) investing activities | -12,105 | -14,544 |
Cash flows from financing activities | ||
Net increase (decrease) in short-term borrowings | -860 | 895 |
Repayments of lease liabilities | -3,172 | -3,384 |
Purchase of treasury shares | -0 | - |
Dividends paid | -792 | -793 |
Dividends paid to non-controlling interests | -30 | -105 |
Proceeds from exercise of employee share options | 159 | 311 |
Income from capital increase of consolidated subsidiaries | - | 8,572 |
Net cash provided by (used in) financing activities | -4,696 | 5,495 |
Effect of exchange rate change on cash and cash equivalents | 1,278 | 858 |
Net increase (decrease) in cash and cash equivalents | -5,579 | 5,537 |
Cash and cash equivalents at beginning of period | 18,748 | 13,169 |
Increase in cash and cash equivalents resulting from inclusion of subsidiaries in consolidation | - | 233 |
Cash and cash equivalents at end of period | 13,169 | 18,940 |